Patent · US Active

Compounds useful for treating a Mannheimia haemolytica or Histophilus somni infection

US12077488B2 · kind B2 · utility

0Cited by

3References

7Claims

0Family size

Assignee

Intervet Inc. · US

Inventors

Michael Berger · Wiesbaden, DE
Thorsten Meyer · Bad Kreuznach, DE
Joachim Ullrich · Stuttgart, DE
Ralf Warrass · Alzey, DE

Key dates

Filing date	May 10, 2021
Grant date	Sep 3, 2024
Priority date	—
Expiry date	Dec 19, 2041

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A40/70
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention discloses compounds that are useful in the treatment of respiratory diseases of animals, especially Bovine or Swine Respiratory disease (BRD and SRD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.